TIDMCTI
RNS Number : 6856B
Cathay International Holdings Ld
20 June 2016
Cathay International Holdings Limited
("Cathay" or the "Company")
Results of Annual General Meeting ("AGM")
Hong Kong, 20 June 2016 - Cathay International Holdings Ltd.
(LSE: CTI.L), a leading operator and investor in the growing
healthcare sector in the People's Republic of China, today
announces that at the AGM held earlier today, all resolutions as
set out in the Notice of AGM dated 22 April 2016 were duly passed.
The final poll voting results for each resolution are shown in the
table below:
Ordinary resolutions For Against Total Withheld
votes
------------------------------------- ------------ -------- ------------ ---------
1. Report and Accounts 445,770,251 145,131 445,915,382 16,414
------------------------------------- ------------ -------- ------------ ---------
2. Re-election of
Mr. Lee Jin-Yi 445,907,374 21,186 445,928,560 3,236
------------------------------------- ------------ -------- ------------ ---------
3. Re-election of
Mr. Siu Ka Chi Eric 445,782,274 148,186 445,930,460 1,336
------------------------------------- ------------ -------- ------------ ---------
4. Re-election of
Mr. Patrick Sung 445,782,274 148,186 445,930,460 1,336
------------------------------------- ------------ -------- ------------ ---------
5. Re-election of
Dr. Chan Ching Har
Eliza
* all shareholders 445,902,620 27,480 445,930,100 1,336
* independent shareholders 55,760,666 27,480 55,788,146 1,336
------------------------------------- ------------ -------- ------------ ---------
6. Reappointment
of Auditor 445,777,450 151,110 445,928,560 3,236
------------------------------------- ------------ -------- ------------ ---------
7. Authority to
allot new shares 445,787,573 139,456 445,927,029 4,767
------------------------------------- ------------ -------- ------------ ---------
Special resolutions For Against Total Withheld
votes
------------------------ ------------ ----------- ------------ ---------
8. Disapplication
of pre-emption rights 401,050,757 44,861,437 445,912,194 19,602
------------------------ ------------ ----------- ------------ ---------
9. Authority to
purchase own shares 445,923,946 6,514 445,930,460 1,336
------------------------ ------------ ----------- ------------ ---------
Notes:
1. Any proxy votes which are at the discretion of the Chairman
have been included in the 'For' total.
2. A vote 'Withheld' is not a vote in law and is not counted in
the calculation of the proportion of the votes for and against a
resolution.
A copy of the resolutions passed at the meeting is being
uploaded today to the National Storage Mechanism and will shortly
be available for viewing at www.morningstar.com.
The proxy figures for the resolutions will also be displayed on
the Company website at www.cathay-intl.com.hk
- ENDS -
For further enquiries, please contact:
Cathay International Holdings
Limited Tel: +852 2828 9289
Eric Siu (Finance Director)
Patrick Sung (Director and
Controller)
Consilium Strategic Communications
Mary-Jane Elliott / Matthew Tel: +44 (0) 203
Neal / Lindsey Neville 709 5702
About Cathay
Cathay International Holdings Limited (LSE: CTI.L) is a main
market listed investment holding company and a leading operator and
investor in the growing healthcare sector in the People's Republic
of China (the "PRC").
The Company and its subsidiaries (collectively the "Group") aim
to leverage on growth opportunities in the strong and growing
domestic demand for high quality healthcare products in the PRC and
build its portfolio companies into market sector leaders with
competitive edge. Cathay has already demonstrated a strong track
record of identifying high-growth potential investment
opportunities in this area including: Lansen, a leading specialty
pharmaceutical company focused on rheumatology and dermatology in
the PRC; Haizi, a company engaged in the manufacture, marketing and
sale of inositol and its by-product, di-calcium phosphate;
Yangling, a company engaged in production and sales of plant
extracts for use as key active ingredients in healthcare products;
and Botai, a company engaged in collagen products.
The Group employs approximately 2,000 people across the PRC,
including over 30 specialist corporate and business development
staff based at the holding company's offices in Hong Kong and
Shenzhen. Cathay also has a hotel investment.
For more information please visit the Company's website:
www.cathay-intl.com.hk
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGFMMMTMBBTBAF
(END) Dow Jones Newswires
June 20, 2016 06:17 ET (10:17 GMT)
Cathay International Hol... (LSE:CTI)
Historical Stock Chart
From Apr 2024 to May 2024
Cathay International Hol... (LSE:CTI)
Historical Stock Chart
From May 2023 to May 2024